BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Leukemia

1. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. MPL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. CEBPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. TCF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. IKZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. MECOM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. MLLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. TET2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. CD52
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. ZBTB16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. MYH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. PBX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. BTK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. HOXA9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. ASXL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. SYK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. NUP98
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. TCL1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. LCK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. LIFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. GATA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. CBFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. MLLT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. MLLT10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. FIP1L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. SF3B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. LMO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. JAK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. TLX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. BCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. HERPUD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. CD79B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. DAXX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. GATA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. SRSF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. PICALM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. DEK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. RUNX1T1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. ELL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. XPO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. FLI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. TLX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. CARS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. NUP214
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. TNFAIP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. MN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. IL7R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. IGK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. CRLF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. HLF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. MKL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. NCOR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. ZNF198
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. EBF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. CSF3R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. KMT2D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. AFF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. IGL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. IRF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. CBFA2T3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. NSD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. SETBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. BCL11B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. NCOR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. ARHGEF12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. B2M
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. LEF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. BCL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. HOXD13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. FCGR2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. LYL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. RECQL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. BCL11A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. PCSK7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. ATRX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. TOP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. KDM6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. LMO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. SND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. KMT2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. NUMA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. MLF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. BCL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. PRDM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. RBM15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. WHSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. SEPT9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. CTCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. SUZ12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. AFF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. BTG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. MTCP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. NCOA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. PRDM16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. TNFRSF17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. PHF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. SH2B3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. TCF12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. KAT6B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. CIITA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. ERCC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. MAP2K4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. MLLT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. TET1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. FOXP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. FANCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. MAP3K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
306. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
307. PPM1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
308. SBDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
309. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
310. BCOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
311. DDX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
312. MALT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
313. NTRK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
314. CCND3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
315. BUB1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [